{"schema_version":"1","generated_at":"2026-11-08T11:02:55.321Z","data_as_of":null,"url":"https://www.findmykol.com/kol/michael-ryskin","json_url":"https://www.findmykol.com/kol/michael-ryskin/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"michael-ryskin","name":"Michael Ryskin","credential":"MD","specialty":"Obstetrics & Gynecology","specialty_raw":"Obstetrics & Gynecology","therapeutic_area":"Gynecologic","therapeutic_areas":["Gynecologic"],"institution":"Pfizer","institution_url":"https://www.findmykol.com/institution/pfizer","city":"Bloomington","state":"IN","region":{"label":"Midwest","url":"https://www.findmykol.com/region/midwest"}},"identifiers":{"npi":"1326007774","openalex":"A5023597240"},"summary":"Michael Ryskin is a Gynecologic physician affiliated with Pfizer. OpenAlex indexes 17 publications with 245 citations (h-index 6).","overview":null,"focus":{"indications":[],"research_topics":["Gynecologic"]},"scholarship":{"works_count":17,"cited_by_count":245,"h_index":6,"latest_activity_year":2025,"source":"works"},"payments":{"company_count":5,"program_years":{"first":2021,"last":null},"rows_total":6,"shown":3,"withheld":3,"rows":[{"payer":"INTUITIVE SURGICAL, INC.","program_year":2025,"amount_usd":5840.1,"payment_count":11,"source_url":"https://openpaymentsdata.cms.gov/search?query=1326007774"},{"payer":"Solventum Corporation","program_year":2025,"amount_usd":19.89,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1326007774"},{"payer":"CooperSurgical, Inc.","program_year":2025,"amount_usd":17.12,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1326007774"}],"record_url":"https://openpaymentsdata.cms.gov/search?query=1326007774","source":"payments"},"publications":{"total":17,"shown":5,"withheld":12,"matched_by":"OpenAlex author record","recent":[{"title":"Design and Synthesis of Pyridone-Containing 3,4-Dihydroisoquinoline-1(2 H )-ones as a Novel Class of Enhancer of Zeste Homolog 2 (EZH2) Inhibitors","year":2016,"journal":"Journal of Medicinal Chemistry","source_url":"https://doi.org/10.1021/acs.jmedchem.6b00515","status":"verified"},{"title":"Correction to Design and Synthesis of Pyridone-Containing 3,4-Dihydroisoquinoline-1(2H)-ones as a Novel Class of Enhancer of Zeste Homolog 2 (EZH2) Inhibitors","year":2016,"journal":"Journal of Medicinal Chemistry","source_url":"https://doi.org/10.1021/acs.jmedchem.6b01747","status":"verified"},{"title":"Reciprocal regulation of amino acid import and epigenetic state through Lat1 and EZH2","year":2015,"journal":"The EMBO Journal","source_url":"https://doi.org/10.15252/embj.201488166","status":"verified"},{"title":"Epigenetic reprogramming by tumor-derived EZH2 gain-of-function mutations promotes aggressive 3D cell morphologies and enhances melanoma tumor growth","year":2015,"journal":"Oncotarget","source_url":"https://doi.org/10.18632/oncotarget.2758","status":"verified"},{"title":"Epigenetic Reprogramming in Solid Tumors: Therapeutic Implications of EZH2 Gain-Of-Function Mutations","year":2015,"journal":"Epigenomics","source_url":"https://doi.org/10.2217/epi.15.27","status":"verified"}],"source":"works"},"similar":[{"name":"Johanna Bendell","slug":"johanna-bendell","institution":"Pfizer","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/johanna-bendell","json_url":"https://www.findmykol.com/kol/johanna-bendell/profile.json"},{"name":"Yoshiko Umeyama","slug":"yoshiko-umeyama","institution":"Pfizer","url":"https://www.findmykol.com/kol/yoshiko-umeyama","json_url":"https://www.findmykol.com/kol/yoshiko-umeyama/profile.json"},{"name":"Lídia Sànchez-Riera","slug":"lidia-sanchez-riera","institution":"Pfizer","url":"https://www.findmykol.com/kol/lidia-sanchez-riera","json_url":"https://www.findmykol.com/kol/lidia-sanchez-riera/profile.json"},{"name":"Philip Dormitzer","slug":"philip-dormitzer","institution":"Pfizer","specialty":"Internal Medicine","url":"https://www.findmykol.com/kol/philip-dormitzer","json_url":"https://www.findmykol.com/kol/philip-dormitzer/profile.json"},{"name":"Baha Sibai","slug":"baha-sibai","institution":"McGovern Medical School at UTHealth Houston","specialty":"Maternal & Fetal Medicine","url":"https://www.findmykol.com/kol/baha-sibai","json_url":"https://www.findmykol.com/kol/baha-sibai/profile.json"},{"name":"Robert Coleman","slug":"robert-coleman","institution":"Vaniam Group","specialty":"Gynecologic Oncology","url":"https://www.findmykol.com/kol/robert-coleman","json_url":"https://www.findmykol.com/kol/robert-coleman/profile.json"},{"name":"Bradley Monk","slug":"bradley-monk","institution":"Florida Cancer Specialists & Research Institute","specialty":"Gynecologic Oncology","url":"https://www.findmykol.com/kol/bradley-monk","json_url":"https://www.findmykol.com/kol/bradley-monk/profile.json"},{"name":"Angeles Secord","slug":"angeles-secord","institution":"Duke University School of Medicine","specialty":"Gynecologic Oncology","url":"https://www.findmykol.com/kol/angeles-secord","json_url":"https://www.findmykol.com/kol/angeles-secord/profile.json"}],"coverage":{"note":"A basic directory record. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["funding","congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"payments":3,"publications":12}},"sources":{"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 onward"}},"methodology_url":"https://www.findmykol.com/about#methodology"}